19th Apr 2006 17:09
GlaxoSmithKline PLC19 April 2006 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the interests of Directors, PersonsDischarging Managerial Responsibility or Connected Persons in the OrdinaryShares of GlaxoSmithKline plc. 10 April 2006 The Administrators of the SmithKline Beecham Employee Benefit Trust ("the Trust") notified the Company on 18 April 2006 that 18 Ordinary shares in the Company had been transferred on 10 April 2006 from the Trust to a participant in the GlaxoSmithKline Annual Investment Plan. 11 April 2006 The Trust also notified the Company on 18 April 2006 that 761 Ordinary shares in the Company had been purchased on 11 April 2006 on behalf of participants in the SmithKline Beecham Bonus Investment Plan at a price of £14.92. 11 April 2006 The Trust also notified the Company on 18 April 2006 that 9,518 Ordinary shares had been purchased on behalf of participants in the GlaxoSmithKline Annual Investment Plan at a price of £14.92. The Trust is a discretionary fund of which all non US employees or formeremployees of GlaxoSmithKline plc and its subsidiaries are potentialbeneficiaries. One of the Company's directors, Mr J Heslop is thereforeinterested in the shares held in the fund from time to time in the same way asother non US employees or former employees of GlaxoSmithKline plc and itssubsidiaries. This notification relates to a transaction notified in accordance withDisclosure Rule 3.1.4R(1)(b). S M BicknellCompany Secretary 19 April 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline